-transparent.png){kind=logo}
The effects of chelation therapy by intravenous and intraperitoneal administration of deferoxamine were compared during maintenance continuous ambulatory peritoneal dialysis (CAPD) in a child with end stage renal disease and hemosiderosis. We demonstrate that intraperitoneally administered deferoxamine is safer, more practical and efficient than weekly intravenously administered deferoxamine for the treatment of iron overload in the pediatric patient undergoing CAPD.
Related Publications
R A Gomez, and
F Campbell, and
J Savory, and
R L Chevalier
November 1984,
Deutsche medizinische Wochenschrift (1946),
R A Gomez, and
F Campbell, and
J Savory, and
R L Chevalier
February 1981,
Chirurgia e patologia sperimentale,
R A Gomez, and
F Campbell, and
J Savory, and
R L Chevalier
November 1984,
Deutsche medizinische Wochenschrift (1946),
R A Gomez, and
F Campbell, and
J Savory, and
R L Chevalier
January 1991,
Advances in peritoneal dialysis. Conference on Peritoneal Dialysis,
R A Gomez, and
F Campbell, and
J Savory, and
R L Chevalier
January 1970,
Sangre,
R A Gomez, and
F Campbell, and
J Savory, and
R L Chevalier
July 1982,
Mayo Clinic proceedings,
R A Gomez, and
F Campbell, and
J Savory, and
R L Chevalier
June 1989,
Kidney international,
R A Gomez, and
F Campbell, and
J Savory, and
R L Chevalier
November 1985,
Deutsche medizinische Wochenschrift (1946),
R A Gomez, and
F Campbell, and
J Savory, and
R L Chevalier
January 1999,
American journal of hematology,
R A Gomez, and
F Campbell, and
J Savory, and
R L Chevalier
July 1987,
Polskie Archiwum Medycyny Wewnetrznej,
